DE69811905T2 - Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel - Google Patents

Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel

Info

Publication number
DE69811905T2
DE69811905T2 DE69811905T DE69811905T DE69811905T2 DE 69811905 T2 DE69811905 T2 DE 69811905T2 DE 69811905 T DE69811905 T DE 69811905T DE 69811905 T DE69811905 T DE 69811905T DE 69811905 T2 DE69811905 T2 DE 69811905T2
Authority
DE
Germany
Prior art keywords
chain alcohol
long chain
product containing
medicinal product
cyclohexenone long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69811905T
Other languages
English (en)
Other versions
DE69811905D1 (de
Inventor
Bang Luu
Gaby Schmitt
Florence Keyling
Celine Girlanda
Masashi Yamada
Yukie Suma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Meiji Co Ltd
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Publication of DE69811905D1 publication Critical patent/DE69811905D1/de
Application granted granted Critical
Publication of DE69811905T2 publication Critical patent/DE69811905T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69811905T 1997-08-13 1998-08-11 Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel Expired - Lifetime DE69811905T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21847497 1997-08-13
PCT/JP1998/003560 WO1999008987A1 (en) 1997-08-13 1998-08-11 Cyclohexenone long-chain alcohol and medicament containing same

Publications (2)

Publication Number Publication Date
DE69811905D1 DE69811905D1 (de) 2003-04-10
DE69811905T2 true DE69811905T2 (de) 2003-11-06

Family

ID=16720502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811905T Expired - Lifetime DE69811905T2 (de) 1997-08-13 1998-08-11 Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel

Country Status (7)

Country Link
US (1) US6228893B1 (de)
EP (1) EP1003706B1 (de)
JP (1) JP3766591B2 (de)
AT (1) ATE233724T1 (de)
CA (1) CA2299308C (de)
DE (1) DE69811905T2 (de)
WO (1) WO1999008987A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4469441B2 (ja) 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
JP4490536B2 (ja) * 2000-01-31 2010-06-30 明治乳業株式会社 脳血管障害に基づく疾患の予防又は治療薬
JP2002068973A (ja) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd 幹細胞分化誘導促進剤
EP1322748B1 (de) * 2000-10-04 2009-12-02 Meiji Dairies Corporation Stemzelldifferenzierung induzierende promoter
JP4250882B2 (ja) * 2000-10-18 2009-04-08 住友化学株式会社 スルホン誘導体およびその製造方法
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
JP3836684B2 (ja) * 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
WO2002094252A1 (en) * 2001-05-24 2002-11-28 Meiji Dairies Corporation Preventive or remedy for diseases caused by cerebrovascular disturbances
AU2003235672A1 (en) * 2002-01-09 2003-07-30 Trident Sciences Llc Compounds for blocking androgen receptors
JP4035332B2 (ja) * 2002-01-22 2008-01-23 明治乳業株式会社 シクロヘキセノン長鎖アルコールの製造法
EP1533299A4 (de) 2002-07-19 2007-04-04 Meiji Dairies Corp Indolderivate und arzneimittel, die diese enthalten
WO2004087630A1 (en) 2003-03-28 2004-10-14 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
KR101194137B1 (ko) * 2004-10-13 2012-10-25 가부시키가이샤 메이지 ＳＴＡＴ３ 인산화 억제 및 Ｎｏｔｃｈ１ 발현 억제제
EP2196200A1 (de) * 2005-01-18 2010-06-16 Meiji Dairies Corporation Cyclohexenonderivat zur Prävention oder Behandlung von Hypästhesie oder durch Diabetes verursachter Hyperästhesie
JP5150807B2 (ja) * 2005-02-28 2013-02-27 株式会社明治 ハイドロキノン長鎖誘導体及び／又はフェノキシ長鎖誘導体及びこれらを含有する医薬
US20080312336A1 (en) * 2005-05-26 2008-12-18 Keisuke Satoh Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder
WO2013147072A1 (ja) * 2012-03-29 2013-10-03 大鵬薬品工業株式会社 3-(15-ヒドロキシペンタデシル)-2,4,4-トリメチル-2-シクロヘキセン-1-オンの共結晶
JP5566521B1 (ja) 2013-09-27 2014-08-06 大鵬薬品工業株式会社 膀胱・尿道協調不全改善剤
US20170035705A1 (en) 2015-08-04 2017-02-09 Taiho Pharmaceutical Co., Ltd. Detrusor hyperactivity with impaired contractility ameliorating agent
KR102387362B1 (ko) 2016-01-22 2022-04-15 다이호야쿠힌고교 가부시키가이샤 고순도 시클로헥세논 장쇄 알코올의 제조 방법
JP2022013721A (ja) 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤
BR112023001832A2 (pt) * 2020-08-07 2023-02-23 Taiho Pharmaceutical Co Ltd Composto cicloalquenona ou sal do mesmo
WO2023153422A1 (ja) * 2022-02-09 2023-08-17 大鵬薬品工業株式会社 シクロヘキセノン化合物の結晶形

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04502167A (ja) * 1989-10-13 1992-04-16 メダフオール 長鎖脂肪アルコール誘導体、特に細胞栄養分子及び細胞保護分子としてのその使用、並びに、該誘導体を含有する医薬組成物
EP0593831B1 (de) * 1992-11-18 1994-05-04 Medafor Langkettige Fettalkohole mit neurotropischer und gedächtnissfördernder Wirkung

Also Published As

Publication number Publication date
EP1003706A1 (de) 2000-05-31
CA2299308A1 (en) 1999-02-25
JP3766591B2 (ja) 2006-04-12
JP2001515058A (ja) 2001-09-18
US6228893B1 (en) 2001-05-08
EP1003706B1 (de) 2003-03-05
DE69811905D1 (de) 2003-04-10
WO1999008987A1 (en) 1999-02-25
ATE233724T1 (de) 2003-03-15
CA2299308C (en) 2008-03-25

Similar Documents

Publication Publication Date Title
DE69811905T2 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
ATE264337T1 (de) Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
TNSN05104A1 (fr) Derives de thiazole pour le traitement de troubles neurodegeneratifs
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ATE270884T1 (de) Langkettiger cyclohexenonalkohol zur behandlung von amyotropher lateraler sklerose
DE69512208T2 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
ATE169635T1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
DE60238666D1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
ES2041679T3 (es) Compuestos analgesicos de octohidroindolizinas 5-substituidas y productos intermedios 7-ceto.
HUP0103017A2 (hu) Kognitív funkciók károsodásával járó kórképek kezelésére szolgáló gyógyászati készítmény és alkalmazása
FR2700165B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
DE69625226D1 (de) Neue n-acetylierte 4-hydroxyphenylaminen derivate mit analgetischen eigenschaften sowie diese enthaltende arzneimittel
FR2721314B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
CA2348319A1 (en) Cyclohexenol derivative and medicament containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1003706

Country of ref document: EP

Representative=s name: GUENTER WAECHTERSHAEUSER, DE

R081 Change of applicant/patentee

Ref document number: 1003706

Country of ref document: EP

Owner name: UNIVERSITE DE STRASBOURG, FR

Free format text: FORMER OWNER: MEIJI CO., LTD., TOKYO, JP

Effective date: 20120911

Ref document number: 1003706

Country of ref document: EP

Owner name: MEIJI CO., LTD., JP

Free format text: FORMER OWNER: MEIJI CO., LTD., TOKYO, JP

Effective date: 20120911

Ref document number: 1003706

Country of ref document: EP

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Free format text: FORMER OWNER: MEIJI CO., LTD., TOKYO, JP

Effective date: 20120911

R082 Change of representative

Ref document number: 1003706

Country of ref document: EP

Representative=s name: GUENTER WAECHTERSHAEUSER, DE

Effective date: 20120911